SCHEMBL29280309

SCHEMBL29280309

Cc1ccc(CC[O])c(Br)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C19 P33261 1/20 0.35
HPGD P15428 6/20 0.35
MAPT P10636 3/20 0.35
ALDH1A1 P00352 2/20 0.35
KMT2A Q03164 2/20 0.35
GAA P10253 2/20 0.35
HTR2A P28223 1/20 0.34
HTR2C P28335 1/20 0.34
HTR2B P41595 1/20 0.34
NPC1 O15118 5/20 0.33
RAB9A P51151 5/20 0.33
TDP1 Q9NUW8 4/20 0.33
SMN1; SMN2 Q16637 3/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
KDM4E B2RXH2 1/20 0.33
SRC P12931 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21032335 0.83 CYP1A2 (0.41) TAAR1CYP1A2CYP2D6CYP2C19HPGD
SCHEMBL16958419 0.81 L3MBTL1 (0.38) TAAR1CYP1A2CYP2D6CYP2C19HPGD
SCHEMBL4547157 0.80 MAPT (0.41) CYP1A2CYP2D6CYP2C19HPGDMAPT
SCHEMBL5981997 0.79 TAAR1 (0.59) TAAR1CYP1A2HTR2AHTR2CHTR2B
SCHEMBL17429675 0.79 SMN1; SMN2 (0.37) TAAR1CYP1A2CYP2D6CYP2C19HPGD
SCHEMBL18378343 0.78 HSP90AA1 (0.43) TAAR1HPGDMAPTALDH1A1KMT2A
SCHEMBL8036416 0.78 TAAR1 (0.42) TAAR1MAPTALDH1A1KMT2AGAA
SCHEMBL10817318 0.78 AMY1A (0.42) TAAR1CYP1A2CYP2D6CYP2C19HPGD
SCHEMBL13967755 0.77 NPSR1 (0.53) MAPTALDH1A1KMT2AGAASRC
SCHEMBL16358426 0.76 ALOX15 (0.36) TAAR1CYP1A2CYP2D6CYP2C19HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111925360-B 1-heterocyclylisochromanyl compounds and analogs for the treatment of CNS disorders 赛诺维信制药公司 2024-03-22 CN disclosed